HC Wainwright & Co. Maintains Buy on 89bio, Lowers Price Target to $29

Benzinga · 05/10 12:09
HC Wainwright & Co. analyst Ed Arce maintains 89bio (NASDAQ:ETNB) with a Buy and lowers the price target from $31 to $29.